Sensei Biotherapeutics Reports Shareholder Vote Matters
Ticker: SNSE · Form: 8-K · Filed: Jun 13, 2024 · CIK: 1829802
| Field | Detail |
|---|---|
| Company | Sensei Biotherapeutics, Inc. (SNSE) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance
TL;DR
Sensei Biotherapeutics held a shareholder vote on June 11th, impacting common and preferred stock.
AI Summary
Sensei Biotherapeutics, Inc. filed an 8-K on June 13, 2024, reporting on matters submitted to a vote of security holders on June 11, 2024. The filing details actions related to common stock and Series A preferred stock.
Why It Matters
This filing indicates that Sensei Biotherapeutics held a shareholder vote, which could lead to changes in corporate governance or strategic direction.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote and does not indicate immediate financial distress or significant operational changes.
Key Players & Entities
- Sensei Biotherapeutics, Inc. (company) — Registrant
- June 11, 2024 (date) — Date of earliest event reported
- June 13, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Rockville, MD (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Sensei Biotherapeutics' security holders on June 11, 2024?
The filing indicates that matters were submitted to a vote of security holders on June 11, 2024, relating to common stock and Series A preferred stock, but the specific proposals are not detailed in this excerpt.
What is the principal business of Sensei Biotherapeutics, Inc.?
Sensei Biotherapeutics, Inc. is in the Pharmaceutical Preparations industry, SIC code 2834.
Where are Sensei Biotherapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 1405 Research Blvd, Suite 125, Rockville, MD 20850.
What is the fiscal year end for Sensei Biotherapeutics, Inc.?
The fiscal year end for Sensei Biotherapeutics, Inc. is December 31st.
What is the Commission File Number for Sensei Biotherapeutics, Inc.?
The Commission File Number for Sensei Biotherapeutics, Inc. is 001-39980.
Filing Stats: 567 words · 2 min read · ~2 pages · Grade level 11.4 · Accepted 2024-06-13 16:45:34
Filing Documents
- d806149d8k.htm (8-K) — 30KB
- 0001193125-24-160769.txt ( ) — 189KB
- snse-20240611.xsd (EX-101.SCH) — 4KB
- snse-20240611_def.xml (EX-101.DEF) — 14KB
- snse-20240611_lab.xml (EX-101.LAB) — 23KB
- snse-20240611_pre.xml (EX-101.PRE) — 15KB
- d806149d8k_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sensei Biotherapeutics, Inc. Date: June 13, 2024 /s/ Christopher W. Gerry Christopher W. Gerry General Counsel and Secretary 3